The Food and Drug Administration has released an update on its work to develop a strategy to help prevent Cronobacter sakazakii illnesses related to powdered infant formula.
The agency is working on the strategy as
Continue Reading FDA continues work on a plan to reduce infant illnesses from Cronobacter in formulas
— OPINION —
The Abbott infant formula recall could have been prevented. The FDA had reports of safety failures months before the contaminated formula sickened babies and caused two deaths.
I sent these T-shirts to
Continue Reading Publisher’s Platform: For babies’ sake, make Cronobacter sakazakii reportable
Top FDA officials are calling on manufacturers of infant formula to clean up their act.
In a letter this week Robert M. Califf, FDA Commissioner, and Susan T. Mayne, Director of the Center for Food
Continue Reading FDA wants infant formula manufacturers to step up work to prevent contamination
— OPINION —
New York Times columnist Thomas Friedman once wrote; “Everything really important happens the morning after the morning after…”
In short, focus on what really changes, not what is said will change.
That
Continue Reading The FDA plan: The morning after the morning after
Today Frank Yiannas informed Commissioner Robert Califf of the U. S. Food and Drug Administration that he will be resigning his position as Deputy Commissioner for the Office of Food Policy and Response at the
Continue Reading Frank Yiannas, Deputy Commissioner of Food Policy and Response, submits his resignation
Abbott Laboratories’ infant-formula plant in Sturgis, MI, is the apparent target of a federal criminal investigation by the U.S. Department of Justice’s Consumer Protection Branch.
The investigation follows the shutdown last year of the Sturgis
Continue Reading Abbott’s formula plant at Sturgis is the target of criminal investigation
With the infant formula shortage moving into its second year, the company most associated with it is making some significant announcements.
Abbott Nutrition let Ohio Gov. Mike DeWine announce that its new $536 million formula
Continue Reading Abbott will expand infant formula production from the Ohio site — but not until 2026.
An outbreak of infections from Salmonella Typhimurium is slowly growing according to the FDA, and an investigation into an outbreak of E. coli infections has been closed.
For the Salmonella outbreak, the number of patients has
Continue Reading Patient count growing in Salmonella outbreak from unknown source; other investigations ongoing
Both the FDA and the USDA have announced new outbreaks, but have provided virtually no details on the situations.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) reports that it is investigating
Continue Reading USDA, FDA relatively mum on new outbreaks
A new outbreak of Listeria monocytogenes infections from a not yet identified food has been added to the list of outbreaks under investigation by the Food and Drug Administration.
There are two confirmed patients, but the FDA
Continue Reading FDA reports another new outbreak of infections from listeria monocytogenes